Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

The management teams of the University of the Free State and the Vista University Bloemfontein campus set the wheels rolling for the incorporation of
2003-05-22

The management teams of the University of the Free State and the Vista University Bloemfontein campus set the wheels rolling for the incorporation of the Vista Bloemfontein campus into the UFS.

The incorporation process will be dealt with in two phases. The first phase would be preparing for a possible incorporation on 1 January 2004, including possible streamlining and review of programmes. The second phase would be part of developing the long term vision or optimal reconfiguration of the Vista facility (within the UFS as a multi-campus institution) in the interests of higher education in the Free State and the communities surrounding the two campuses in Bloemfontein.

At a meeting at the UFS both parties reached consensus about the process and set about establishing task teams to deal with critical issues, such as governance and management, financial management, human resources, information systems, library services, student support and administration, academic planning and academic programmes.

Prof Talvin Schultz, Head of the Vista Bloemfontein campus, committed this campus to making the process of incorporation into the UFS an exemplary process. UFS Rector Prof Frederick Fourie said the Free State should continue its tradition as a province where things happen and where higher education transformation has proceeded faster than elsewhere in the country.

Both emphasised the need for an inclusive process of consultation with staff, students and the community on key aspects of the incorporation.

They indicated that all planning should take into account a possible date of incorporation of 1 January 2004, pending finalisation by the respective Councils. The Councils of both institutions need to give feedback to the Minister of Education on the date of incorporation by the end of June, and the task teams must deliver an initial report on progress before then.


Prof Talvin Schultz (Vista Bloemfontein campus) and Prof Frederick Fourie (UFS)

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept